pasiniazide has been researched along with isoniazid in 5 studies
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HX; Yu, CL; Yuan, ZB; Zhang, SS | 1 |
| Hu, X; Wang, J; Yu, D | 1 |
| Li, SM; Xing, BC; Zheng, XM | 1 |
| Lu, JM; Sha, W; Xiao, HP; Yang, H; Zhang, LL; Zhang, Q | 1 |
| Jiang, Y; Li, G; Li, M; Liu, H; Wan, K; Zhang, J; Zhao, LL; Zhao, X | 1 |
2 trial(s) available for pasiniazide and isoniazid
| Article | Year |
|---|---|
[Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Radiography; Recurrence; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
3 other study(ies) available for pasiniazide and isoniazid
| Article | Year |
|---|---|
A reproducible, simple, and sensitive high-performance capillary electrophoresis method for simultaneous determination of capreomycin, ofloxacin and pasiniazide in urine.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Capreomycin; Electrophoresis, Capillary; Humans; Isoniazid; Ofloxacin; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1998 |
[Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB].
Topics: Aminosalicylic Acids; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Retreatment; Rifabutin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
Topics: Adult; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Peroxiredoxins; Promoter Regions, Genetic; Repressor Proteins; Tuberculosis, Pulmonary | 2020 |